Introduction
Aneurysmal subarachnoid hemorrhage (aSAH) is a significant cause of morbidity and mortality, affecting 2-16 people per 100,000 population [1] . Despite decreased mortality rates in recent decades, many survivors have residual deficits and poor neurologic outcomes [2] .
Seizures are a recognized complication of aSAH, occurring in up to 26% of patients [3] [4] [5] [6] . While it appears that seizures are correlated with worse grading of aSAH, their effect on patient outcomes remains unclear [7] . Several studies have suggested an association between seizures and poor outcomes, but others show no clear effect [3, [7] [8] [9] [10] [11] [12] [13] 19, 20] . Most studies to date have been single-center trials, with the potential for variations in care delivery and patient demographics.
The National Inpatient Sample (NIS) is a large inpatient database in the United States that captures over eight million hospital stays annually [14] . The aim of our study was to use a large, nationally-representative dataset to investigate the association between seizures and hospital mortality in a real-world cohort of patients with aSAH in the United States from 2006 to 2011.
Methods
Our study is reported in accordance with the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement [15] . A de-identified dataset was used for this analysis, for which a waiver of consent was obtained from the University of British Columbia Institutional Review Board (H15-01943). The primary outcome for this study was in-hospital mortality.
Study population
We performed a retrospective cohort review using the Nationwide Inpatient Sample (NIS) for [2006] [2007] [2008] [2009] [2010] [2011] [16] . Seizures were defined using ICD9 codes for epilepsy and convulsions, which have been independently validated for the study of seizures [17] . The presence of seizures was defined as a patient having codes for epilepsy (345.0x-345.5x and 345.7x-345.9x) or other convulsions (780.39), similar to other published literature [12] .
Patient level characteristics obtained from the database included age, gender, in-hospital mortality, the 29 Elixhauser comorbidity indices, and length of stay (LOS) [18] . Hospital characteristics gathered included size (small, medium, large as defined by the AHRQ [14] ), region of the country (West, Northeast, Midwest and South), and teaching status (yes vs no).
In order to account for the severity of aSAH, we employed the Nationwide Inpatient Sample Subarachnoid Severity Scale (NIS-SSS) developed by Washington et al. [19] . The NIS-SSS was independently validated to be equivalent to the Hunt and Hess score for predicting six month functional outcomes based on the Modified Rankin Score. 
Statistical analysis
Data were analyzed using SAS v9.4 (Cary, NC). Complex weights were used throughout all calculations, enabling appropriate national projections. Percentages in all tables and figures reflect national estimates. Chi-squared and independent t-tests were used for univariate analysis where appropriate. All statistical modeling was performed with an alpha significance of 0.05 ( Fig. 1) .
A logistic regression model was created utilizing the PROC SURVEYLOGISTIC function in SAS. Variables included in the model of mortality were age, gender, presence of seizures, NIS-SSS score, hospital size, hospital teaching status, hospital region, and the 29 Elixhauser co-morbidity indices. In order to produce accurate results, we removed the ICD9 codes for seizures from the Elixhauser "other neurological disorder" index for the purposes of this analysis.
Results
We examined a total of 47,911,414 hospitalizations from the 2006 to 2011 NIS samples. We identified 12,647 patients with aSAH who met the inclusion criteria for the study, of whom 1336 (10.6%) also carried a diagnosis of seizures. The unadjusted in-hospital mortality was higher for patients with seizures compared to those without (16.2% vs 11.6%, p 0.01; Table 1 ). Compared to those without seizures, patients with seizures were younger (52.4 years SD 13.9 vs 54.8 years, SD 13.6; p < 0.01), more likely to be male (35.6% vs 31.0%, p < 0.01) and had longer hospital stays (18. Seizures were found to be associated with increased mortality after adjusting for other variables (OR for death 1.57, 95% CI 1.32-1.87, p < 0.01) ( Table 2 ). Variables associated with increased mortality in aSAH included: age (per 5 year increase OR 1.16, 95% CI 1.13-1.19, p < 0.01), NIS-SSS (OR 1.019, 95% CI 1.017-1.020, p < 0.01), chronic lung disease (OR 1.23, 95% CI 1.04-1.44, p = 0.01), liver disease (OR 1.91, 95% CI 1.25-2.93, p < 0.01), and renal failure (OR 1.72, 95% CI 1.24-2.39, p < 0.01).
Discussion
In this large, nationally-representative retrospective review, we found that seizures were associated with increased hospital mortality in patients with aSAH. Seizures were more common in younger male patients, and in patients with higher NIS-SSS scores.
Prior research offered conflicting views on the impact of seizures on outcomes in aSAH. While most existing literature supports the association of seizures with worse outcomes [8] [9] [10] [11] 19, 20] , several recent groups have reported either a lack of association, or even an association with positive outcomes [3, 7, 12, 13] . Methodological issues may explain this discrepancy. One study excluded patients "comatose or considered unlikely to survive for more than one week", potentially selecting a nonrepresentative cohort of those with less severe presentation [13] . Others focused exclusively on early-onset seizures, despite evidence that seizures may occur later in the disease course [3, 7, 21] . Furthermore, the detection of seizures, particularly subclinical seizures, may be a proxy for higher-intensity neurocritical care, which may mitigate their deleterious effect [3] . Our work supports the findings of prior small studies showing worse outcomes in aSAH patients with seizures [8] [9] [10] [11] 20, 22] . Several possible mechanisms have been proposed to explain this relationship. Seizures may be a manifestation of inflammation, as they have been found to be associated with higher clinical and laboratory markers of systemic inflammation [19, 23, 24] . Several studies have also documented a relationship between seizures and increased ICP following aSAH [20, 25] , and there may be a role of hypermetabolism and relative tissue hypoxia [11] . In addition, delayed seizures may be linked to delayed cerebral ischemia and cortical spreading depolarizations [26, 27] . Further study is required to clarify the pathophysiology of seizures following aSAH. Finally, the impact of anti-epileptic therapy on outcomes in patients with seizures is unclear, and may pose additional risk in certain patients [22, 28] .
In addition to being associated with higher mortality, we found that seizures were associated with worse NIS-SSS scores, a validated surrogate for aSAH severity [19] . This is consistent with prior data showing that aSAH grading is one of the best predictors of outcome [29] . There has been some suggestion that early seizures may mimic more severe disease states and therefore cause falsely poor initial grading but relatively good outcomes [3, 7] . Our study did not find this, but prospective studies are needed to better define interplay between early seizures and initial grading score.
The strength of this study lies primarily in its size and generalizability. In contrast to previous single-center studies, analysis of patients from a nationwide cohort allows us to investigate outcomes for a much more diverse and representative sample. The ability to control for the severity of aSAH using the NIS-SSS also allowed for more robust modeling. By selecting only patients who received definitive therapy for their aneurysm, we attempted to minimize the inclusion of patients with alternate etiologies of SAH (for example, traumatic SAH), as well as the confounding effect of re-bleeding in untreated patients or patients who were transitioned to comfort care before aneurysmal control.
The results of this study must be interpreted in the context of the study design. Large, database-driven observational studies are inherently susceptible to coding errors and selection bias. The diagnosis of seizures may have pre-dated aSAH, an example of misclassification bias. We were also unable to control for potentially confounding variables shown to be associated with seizures in aSAH, such as location of aSAH, clot burden on computed tomography scan, and associated intracranial hematoma [28, 30, 31] . Furthermore, our data set did not allow us to control for the use or choice of anti-epileptic medications, the presence of delayed cerebral ischemia, or re-bleeding before aneurysmal control. We were also unable to evaluate the effect of aSAH-related seizures on long-term post-discharge outcomes.
Conclusion
In this large retrospective study of patients with aSAH across the United States, the presence of seizures was associated with increased in-hospital mortality and worse NIS-SSS score. This supports previous smaller-scale studies demonstrating this association. Further work clarifying the pathophysiology and treatment of aSAH-related seizures is needed to optimize neurocritical care of this patient group. 
